Mitochondrial pathophysiology and type 2 diabetes mellitus

Archives of Physiology and Biochemistry

Volumn 117, Issue 3, 2011, Pages 177-187

  Garcia Roves, Pablo M ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

energy metabolism; Insulin resistance; obesity; oxidative phosphorylation

Indexed keywords

INSULIN;

ANIMAL; CONFERENCE PAPER; ENERGY METABOLISM; HUMAN; HYPOTHALAMUS; INSULIN RESISTANCE; LIVER; METABOLISM; MITOCHONDRION; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PHYSIOLOGY; SKELETAL MUSCLE; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE, WHITE; ANIMALS; DIABETES MELLITUS, TYPE 2; ENERGY METABOLISM; HUMANS; HYPOTHALAMUS; INSULIN; INSULIN RESISTANCE; LIVER; MITOCHONDRIA; MUSCLE, SKELETAL;

EID: 79959207992     PISSN: 13813455     EISSN: 17444160     Source Type: Journal    
DOI: 10.3109/13813455.2011.584538     Document Type: Conference Paper

References (119)

1. Abdul-Ghani MA, Muller, FL, Liu Y, Chavez AO, Balas B, Zuo P, Chang Z, Tripathy D, Jani R, Molina-Carrion M, et al (2008). Deleterious action of FA metabolites on ATP synthesis: possible link between lipotoxicity, mitochondrial dysfunction, and insulin resistance. Am J Physiol Endo Metab 295:E678-85
2. Andrews ZB, Liu Z-W, Wallingford N, Erion DM, Borok E, Friedman JM, Tschop MH, Shanabrough M, Cline G, Shulman GI, et al (2008). UCP2 mediates ghrelin/'s action on NPY/AgRP neurons by lowering free radicals. Nature 454:846-51.
3. Asmann YW, Stump CS, Short KR, Coenen-Schimpke JM, Guo Z, Bigelow ML, Nair KS. (2006). Skeletal muscle mitochondrial functions, mitochondrial DNA copy numbers, and gene transcript profiles in Type 2 diabetic and nondiabetic subjects at equal levels of low or high insulin and euglycemia. Diabetes 55:3309-19. (Pubitemid 44923587)
4. Balaban RS. (2010). Te mitochondrial proteome: A dynamic functional program in tissues and disease states. Environ Molec Mutagen 51:352-9.
5. Befroy DE, Petersen KF, Dufour S, Mason GF, de Graaf RA, Rothman DL, Shulman GI. (2007). Impaired mitochondrial substrate oxidation in muscle of insulin-resistant ofspring of Type 2 diabetic patients. Diabetes 56:1376-81. (Pubitemid 46715630)
6. Benani A, Barquissau V, Carneiro L, Salin B, Colombani A-L, Leloup C, Casteilla L, Rigoulet M, Pénicaud L. (2009). Method for functional study of mitochondria in rat hypothalamus. J Neurosc Meth 178:301-7.
7. Blüher M, Michael MD, Peroni OD, Ueki K, Carter N, Kahn BB, Kahn CR. (2002). Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. Devel Cell 3:25-38. (Pubitemid 34778393)
8. Boden G, Homko C, Mozzoli M, Showe LC, Nichols C, Cheung P. (2005). Tiazolidinediones upregulate fatty acid uptake and oxidation in adipose tissue of diabetic patients. Diabetes 54:880-85. (Pubitemid 40322094)
9. Bonnard C, Durand A, Peyrol S, Chanseaume E, Chauvin M-A, Morio BA, Vidal H, Rieusset J. (2008). Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice. J Clin Invest 118:789-800. (Pubitemid 351206566)
10. Bordenave S, Metz L, Flavier S, Lambert K, Ghanassia E, Dupuy AM, Michel F, Puech-Cathala AM, Raynaud E, Brun JF, Mercier J. (2008). Training-induced improvement in lipid oxidation in type 2 diabetes mellitus is related to alterations in muscle mitochondrial activity. Efect of endurance training in type 2 diabetes. Diab Metab 34:162-8.
11. Boushel R, Gnaiger E, Schjerling P, Skovbro M, Kraunsoe R, Del F. (2007). Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle. Diabetologia 50:790-96. (Pubitemid 46355830)
12. Brady LJ, Brady PS, Romsos DR, Hoppel CL. (1985). Elevated hepatic mitochondrial and peroxisomal oxidative capacities in fed and starved adult obese (ob/ob) mice. Biochem J 231:439-44. (Pubitemid 15244016)
13. Brons C, Jensen CB, Storgaard H, Alibegovic A, Jacobsen S, Nilsson E, Astrup A, Quistorf B, Vaag A. (2008). Mitochondrial function in skeletal muscle is normal and unrelated to insulin action in young men born with low birth weight. J Clin Endo Metab 93:3885-92.
14. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC (2003). Beta-cell defcit and increased Beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102-10. (Pubitemid 36042113)
15. Colombani A-L, Carneiro L, Benani A, Galinier A, Jaillard T, Duparc T, Ofer GR, Lorsignol A, Magnan C, Casteilla L, et al (2009). Enhanced hypothalamic glucose sensing in obesity: Alteration of redox signaling. Diabetes 58:2189-97.
16. Cortez-Pinto H, Chatham J, Chacko VP, Arnold C, Rashid A, Diehl AM. (1999). Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis. JAMA: J Am Med Assoc 282:1659-64. (Pubitemid 29513973)
17. Chalasani N, Gorsk, JC, Asghar MS, Asghar A, Foresman B, Hall SD, Crabb DW. (2003). Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis. Hepatology 37:544-50. (Pubitemid 36258775)
18. Chan DC. (2006). Mitochondria: Dynamic organelles in disease, aging, and development. Cell 125:1241-52. (Pubitemid 43929096)
19. Chevillotte E, Giralt M, Miroux B, Ricquier D, Villarroya F. (2007). Uncoupling protein-2 controls adiponectin gene expression in adipose tissue through the modulation of reactive oxygen species production. Diabetes 56:1042-50. (Pubitemid 46525055)
20. Choo HJ, Kim JH, Kwon OB, Lee CS, Mun JY, Han SS, Yoon YS, Yoon G, Choi KM, Ko YG. (2006). Mitochondria are impaired in the adipocytes of type 2 diabetic mice. Diabetologia 49:784-91. (Pubitemid 43361881)
21. Dahlman I, Forsgren M, Sjogren A, Nordstrom EA, Kaaman M, Naslund E, Attersand A, Arner P. (2006). Downregulation of electron transport chain genes in visceral adipose tissue in type 2 diabetes independent of obesity and possibly involving tumor necrosis factor-alpha. Diabetes 55:1792-9. (Pubitemid 44324134)
22. De Feyter HM, Lenaers E, Houten SM, Schrauwen P, Hesselink MK, Wanders RJ, Nicolay K, Prompers JJ. (2008a). Increased intramyocellular lipid content but normal skeletal muscle mitochondrial oxidative capacity throughout the pathogenesis of type 2 diabetes. Faseb J 22:3947-55.
23. De Feyter HM, van den Broek NM, Praet SF, Nicolay K, van Loon LJ, Prompers JJ. (2008b). Early or advanced stage type 2 diabetes is not accompanied by in vivo skeletal muscle mitochondrial dysfunction. Eur J Endocrinol 158:643-53. (Pubitemid 351639601)
24. De Souza CT, Araujo EP, Stoppiglia LF, Pauli JR, Ropelle E, Rocco SA, Marin RM, Franchini KG, Carvalheira JB, Saad MJ, et al (2007). Inhibition of UCP2 expression reverses diet-induced diabetes mellitus by efects on both insulin secretion and action. FASEB J 21:1153-63. (Pubitemid 46495705)
25. De Wilde J, Mohren R, van den Berg S, Boekschoten M, Dijk KW-V, de Groot P, Müller M, Mariman E, Smit, E. (2008). Short-term high fat-feeding results in morphological and metabolic adaptations in the skeletal muscle of C57BL/6J mice. Physiol Genom 32:360-69. (Pubitemid 351328559)
26. Defronzo RA. (2009). Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 58:773-95.
27. Defronzo RA, Ferrannini E, Simonson DC (1989). Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism 38:387-95. (Pubitemid 19105727)
28. Defronzo RA, Gunnarsson R, Bjorkman O, Olsson M, Wahren J. (1985). Efects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus. J Clin Invest 76:149-55. (Pubitemid 15240430)
29. Deng W-J, Nie S, Dai J, Wu J-R, Zeng R. (2010). Proteome, phosphoproteome, and hydroxyproteome of liver mitochondria in diabetic rats at early pathogenic stages. Mol Cell Proteomics 9:100-16.
30. Drucker DJ, Nauck MA. (2006). Te incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 368:1696-705. (Pubitemid 46048557)
31. Eisenberg BR, Kuda AM. (1975). Stereological analysis of mammalian skeletal muscle. II. White vastus muscle of the adult guinea pig. J Ultrastruct Res 51:176-87.
32. Eisenberg BR, Kuda AM. (1976). Discrimination between fber populations in mammalian skeletal muscle by using ultrastructural parameters. J Ultrastruct Res 54:76-88.
33. Ferrannini E. (1998). Insulin resistance versus insulin defciency in non-insulin-dependent diabetes mellitus: Problems and prospects. Endo Rev 19:477-90. (Pubitemid 29116377)
34. Ferrannini E, Gastaldelli A, Miyazaki Y, Matsuda M, Mari A, Defronzo RA. (2005). ß-cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: A new analysis. J Clin Endo Metab 90:493-500. (Pubitemid 40116699)
35. Ferreira FM, Palmeira CM, Seiça R, Moreno AJ, Santos MS. (2003). Diabetes and mitochondrial bioenergetics: Alterations with age. J Biochem Molec Toxicol 17:214-22. (Pubitemid 36974721)
36. Ferreira FM, Palmeira CM, Seiça R, Santos MS. (1999). Alterations of liver mitochondrial bioenergetics in diabetic Goto-Kakizaki rats. Metabolism 48:1115-19. (Pubitemid 29418280)
37. Flamment M, Arvier M, Gallois Y, Simard G, Malthièry Y, Ritz P, Ducluzeau P-H. (2008). Fatty liver and insulin resistance in obese Zucker rats: No role for mitochondrial dysfunction. Biochimie 90:1407-13.
38. Forner F, Foster LJ, Campanaro S, Valle G, Mann M. (2006). Quantitative proteomic comparison of rat mitochondria from muscle, heart, and liver. Mol Cell Proteomics 5:608-19.
39. Fraser A, Harris R, Sattar N, Ebrahim S, Davey Smith G, Lawlor DA. (2009). Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes. Diabetes Care 32:741-50.
40. Friedman JM. (2009). Obesity: Causes and control of excess body fat. Nature 459:340-42.
41. Gagnon J, Kurowski TT, Wiesner RJ, Zak R. (1991). Correlations between a nuclear and a mitochondrial mRNA of cytochrome c oxidase subunits, enzymatic activity and total mRNA content, in rat tissues. Mol Cell Biochem 107:21-9.
42. Garcia-Roves P, Huss JM, Han D-H, Hancock CR, Iglesias-Gutierrez E, Chen M, Holloszy JO. (2007). Raising plasma fatty acid concentration induces increased biogenesis of mitochondria in skeletal muscle. Proc Nat Acad Sci 104:10709-13. (Pubitemid 47185729)
43. Hammarstedt A, Jansson PA, Wesslau C, Yang X, Smith U. (2003). Reduced expression of PGC-1 and insulin-signaling molecules in adipose tissue is associated with insulin resistance. Biochem Biophys Res Com 301:578-82. (Pubitemid 36279280)
44. Hancock CR, Han DH, Chen M, Terada S, Yasuda T, Wright DC, Holloszy JO. (2008). High-fat diets cause insulin resistance despite an increase in muscle mitochondria. Proc Natl Acad Sci USA 105:7815-20. (Pubitemid 351872721)
45. Hey-Mogensen M, Højlund K, Vind B, Wang L, Dela F, Beck-Nielsen H, Fernström M, Sahlin K. (2010). Efect of physical training on mitochondrial respiration and reactive oxygen species release in skeletal muscle in patients with obesity and type 2 diabetes. Diabetologia 53:1976-85.
46. Holloway GP, Benton CR, Mullen KL, Yoshida Y, Snook LA, Han XX, Glatz JF, Luiken JJ, Lally J, Dyck DJ, Bonen A. (2009). In obese rat muscle transport of palmitate is increased and is channeled to triacylglycerol storage despite an increase in mitochondrial palmitate oxidation. Am J Physiol Endocrinol Metab 296:E738-47
47. Hotamisligil GS. (2006). Infammation and metabolic disorders. Nature 444:860-67.
48. Hotamisligil GS, Erbay E. (2008). Nutrient sensing and infammation in metabolic diseases. Nat Rev Immunol 8:923-34.
49. Iossa S, Lionetti L, Mollica MP, Crescenzo R, Botta M, Barletta A, Liverini G. (2003). Efect of high-fat feeding on metabolic efciency and mitochondrial oxidative capacity in adult rats. Br J Nutr 90:953-60. (Pubitemid 37328069)
50. Johnson DT, Harris RA, French S, Blair PV, You J, Bemis KG, Wang M, Balaban RS. (2007). Tissue heterogeneity of the mammalian mitochondrial proteome. Am J Physiol-Cell Physiol 292:C689-97
51. Kaaman M, Sparks L, van Harmelen V, Smith S, Sjölin E, Dahlman I, Arner P. (2007). Strong association between mitochondrial DNA copy number and lipogenesis in human white adipose tissue. Diabetologia 50:2526-33. (Pubitemid 350060639)
52. Karakelides H, Irving BA, Short KR, O'Brien P, Nair KS. (2010). Age, obesity, and sex efects on insulin sensitivity and skeletal muscle mitochondrial function. Diabetes 59:89-97.
53. Kashiwagi A, Verso MA, Andrews J, Vasquez B, Reaven G, Foley JE. (1983). In vitro insulin resistance of human adipocytes isolated from subjects with noninsulin-dependent diabetes mellitus. J Clin Invest 72:1246-54. (Pubitemid 13013757)
54. Katic M, KennedyAR, Leykin I, Norris A, McGettrick A, Gesta S, Russell SJ, Bluher M, Maratos-Flier E, Kahn CR. (2007). Mitochondrial gene expression and increased oxidative metabolism: role in increased lifespan of fat-specifc insulin receptor knock-out mice. Aging Cell 6:827-39. (Pubitemid 350131051)
55. Kelley DE, Goodpaster B, Wing RR, Simoneau JA. (1999). Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. Am J Physiol 277:E1130-41 (Pubitemid 30046009)
56. Kelley DE, He J, Menshikova EV, Ritov VB. (2002). Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51:2944-50.
57. Koch L, Wunderlich FT, Seibler J, Konner AC, Hampel B, Irlenbusch S, Brabant G, Kahn CR, Schwenk F, Bruning JC. (2008). Central insulin action regulates peripheral glucose and fat metabolism in mice. J Clin Invest 118:2132-47. (Pubitemid 351872332)
58. Koh EH, Park J-Y, Park H-S, Jeon MJ, Ryu JW, Kim M, Kim SY, Kim M-S, Kim S-W, Park IS, Youn JH, Lee K-U. (2007). Essential role of mitochondrial function in adiponectin synthesis in adipocytes. Diabetes 56:2973-81. (Pubitemid 350223632)
59. Kraunsoe R, Boushel R, Hansen CN, Schjerling P, Qvortrup K, Stockel M, Mikines KJ, Dela F. (2010). Mitochondrial respiration in subcutaneous and visceral adipose tissue from patients with morbid obesity. J Physiol 588:2023-32.
60. Lago F, Gómez R, Gómez-Reino JJ, Dieguez C, Gualillo O. (2009). Adipokines as novel modulators of lipid metabolism. Trends Biochem Sci 34:500-10.
61. Laye MJ, Rector RS, Warner SO, Naples SP, Perretta AL, Uptergrove GM, Laughlin MH, Tyfault JP, Booth FW, Ibdah JA. (2009). Changes in visceral adipose tissue mitochondrial content with type 2 diabetes and daily voluntary wheel running in OLETF rats. J Physiol 587:3729-39.
62. Lefort N, Glancy B, Bowen B, Willis WT, Bailowitz Z, de Filippis EA, Brophy C, Meyer C, Hajlund K, Yi Z, Mandarino LJ. (2011). Increased reactive oxygen species production and lower abundance of complex I subunits and carnitine palmitoyltransferase 1B protein despite normal mitochondrial respiration in insulin-resistant human skeletal muscle. Diabetes 59:2444-52.
63. Lenaers E, de Feyter HM, Hoeks J, Schrauwen P, Schaart G, Nabben M, Nicolay K, Prompers JJ, Hesselink MK. (2010). Adaptations in mitochondrial function parallel, but fail to rescue, the transition to severe hyperglycemia and hyperinsulinemia: a study in Zucker diabetic fatty rats. Obesity 18:1100-107.
64. Leonardsson GR, Steel JH, Christian M, Pocock V, Milligan S, Bell J, So P-W, Medina-Gomez G, Vidal-Puig A, White R, Parker MG. (2004). Nuclear receptor corepressor RIP140 regulates fat accumulation. Proc Nat Acad Sci USA 101:8437-42. (Pubitemid 38736593)
65. Liesa M, Palacan M, Zorzano A. (2009). Mitochondrial dynamics in mammalian health and disease. Physiol Rev 89:799-845.
66. Lowell BB, Shulman GI. (2005). Mitochondrial dysfunction and type 2 diabetes. Science 307:384-7. (Pubitemid 40139974)
67. Mantena SK, Vaughn DP, Andringa KK, Eccleston HB, King AL, Abrams GA, Doeller JE, Kraus DW, Darley-Usmar VM, Bailey SM. (2009). High fat diet induces dysregulation of hepatic oxygen gradients and mitochondrial function in vivo. Biochem J 417:183-93.
68. Matsuda M, Liu Y, Mahankali S, Pu Y, Mahankali A, Wang J, Defronzo RA, Fox PT, Gao JH. (1999). Altered hypothalamic function in response to glucose ingestion in obese humans. Diabetes 48:1801-6. (Pubitemid 29415200)
69. Meex RC, Schrauwen-Hinderling VB, Moonen-Kornips E, Schaart G, Mensink M, Phielix E, van de Weijer T, Sels JP, Schrauwen P, Hessellink MK. (2010). Restoration of muscle mitochondrial function and metabolic fexibility in type 2 diabetes by exercise training is paralleled by increased myocellular fat storage and improved insulin sensitivity. Diabetes 59:572-9.
70. Miele L, Grieco A, Armuzzi A, Candelli M, Forgione A, Gasbarrini A, Gasbarrini G. (2003). Hepatic mitochondrial beta-oxidation in patients with nonalcoholic steatohepatitis assessed by 13C-octanoate breath test. Am J Gastroenterol 98:2335-6. (Pubitemid 37305387)
71. Mootha VK, Bunkenborg J, Olsen JV, Hjerrild M, Wisniewski JR, Stahl E, Bolouri MS, Ray HN, Sihag S, Kamal M, et al. (2003a). Integrated analysis of protein composition, tissue diversity, and gene regulation in mouse mitochondria. Cell 115:629-40. (Pubitemid 37508523)
72. Mootha VK, Lindgren CM, Eriksson K-F, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, Ridderstrale M, Laurila E., et al (2003b). PGC-1[alpha]-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34:267-73. (Pubitemid 36792858)
73. Mootha VK, Wei MC, Buttle KF, Scorrano L, Panoutsakopoulou V, Mannella CA, Korsmeyer SJ. (2001). A reversible component of mitochondrial respiratory dysfunction in apoptosis can be rescued by exogenous cytochrome c. Embo J 20:661-71. (Pubitemid 32167631)
74. Mustelin L, Pietiläinen KH, Rissanen A, Sovijärvi AR, Piirila PI, Naukkärinen J, Peltonen L, Kaprio J, Yki-Järvinen H. (2008). Acquired obesity and poor physical ftness impair expression of genes of mitochondrial oxidative phosphorylation in monozygotic twins discordant for obesity. Am J Physiol-Endocrin Metab 295:E148-54
75. Nair KS, Bigelow ML, Asmann YW, Chow LS, Coenen-Schimpke JM, Klaus KA, Guo Z-K, Sreekumar R, Irving BA. (2008). Asian Indians have enhanced skeletal muscle mitochondrial capacity to produce ATP in association with severe insulin resistance. Diabetes 57:1166-75.
76. Obici S, Zhang BB, Karkanias G, Rossetti L. (2002). Hypothalamic insulin signaling is required for inhibition of glucose production. Nat Med 8:1376-82. (Pubitemid 36019422)
77. Ost A, Svensson K, Ruishalme I, Brannmark C, Franck N, Krook H, Sandstrom P, Kjolhede P, Stralfors P. (2010). Attenuated mTOR signaling and enhanced autophagy in adipocytes from obese patients with type 2 diabetes. Mol Med 16, 235-46.
78. Pagel-Langenickel I, Bao J, Pang L, Sack MN. (2010). Te role of mitochondria in the pathophysiology of skeletal muscle insulin resistance. Endo Rev 31:25-51.
79. Patti ME, Butti AJ, Crunkhorn S, Cusi K, Berria R, Kashyap S, Miyazaki Y, Kohane I, Costello M, Saccone R, et al (2003). Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc Natl Acad Sci USA 100:8466-71. (Pubitemid 36842568)
80. Patti ME, Corvera S. (2010). Te role of mitochondria in the pathogenesis of type 2 diabetes. Endocr Rev 31:364-95.
81. Pérez-Carreras M, del Hoyo P, Martín MA, Rubio JC, Martín A, Castellano G, Colina F, Arenas J, Solis-Herruzo JA. (2003). Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. Hepatology 38:999-1007. (Pubitemid 37221683)
82. Perrin C, Knauf C, Burcelin R. (2004). Intracerebroventricular infusion of glucose, insulin, and the adenosine monophosphate-activated kinase activator, 5-aminoimidazole-4-carboxamide-1-ß-D-ribofuranoside, controls muscle glycogen synthesis. Endocrinology 145:4025-33. (Pubitemid 39120547)
83. Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, Rothman DL, Dipietro L, Cline GW, Shulman GI. (2003). Mitochondrial dysfunction in the elderly: Possible role in insulin resistance. Science 300:1140-42. (Pubitemid 36583097)
84. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI. (2004). Impaired mitochondrial activity in the insulin-resistant ofspring of patients with type 2 diabetes. New Eng J Med 350:664-71. (Pubitemid 38364625)
85. Petersen KF, Dufour S, Feng J, Befroy D, Dziura J, Man CD, Cobelli C, Shulman GI. (2006). Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men. Proc Nat Acad Sci 103:18273-7. (Pubitemid 44871648)
86. Phielix E, Meex R, Moonen-Kornips E, Hesselink M, Schrauwen P. (2010). Exercise training increases mitochondrial content and ex vivo mitochondrial function similarly in patients with type 2 diabetes and in control individuals. Diabetologia 53:1714-21.
87. Pihlajamaki J, Boes T, Kim E-Y, Dearie F, Kim BW, Schroeder J, Mun E, Nasser I, Park PJ, Bianco AC, Goldfne AB, Patti ME. (2009). Tyroid hormone-related regulation of gene expression in human fatty liver. J Clin Endocr Metab 94:3521-9.
88. Plum L, Schubert M, Brüning JC. (2005). Te role of insulin receptor signaling in the brain. TEM 16:59-65. (Pubitemid 40270851)
89. Powelka AM, Seth A, Virbasius JV, Kiskinis E, Nicoloro SM, Guilherme A, Tang X, Straubhaar J, Cherniack AD, Parker MG, Czech MP. (2006). Suppression of oxidative metabolism and mitochondrial biogenesis by the transcriptional corepressor RIP140 in mouse adipocytes. J Clin Invest 116:125-36. (Pubitemid 43121797)
90. Rabol R, Larsen S, Hojberg PMV, Almdal T, Boushel R, Haugaard SB, Andersen JL, Madsbad S, Dela F. (2010). Regional anatomic diferences in skeletal muscle mitochondrial respiration in type 2 diabetes and obesity. J Clin Endo Metab 95:857-63.
91. Rafaella C, Francesca B, Italia F, Marina P, Giovanni L, Susanna I. (2008). Alterations in hepatic mitochondrial compartment in a model of obesity and insulin resistance. Obesity 16:958-64. (Pubitemid 351620457)
92. Rector RS, Tyfault JP, Uptergrove GM, Morris EM, Naples SP, Borengasser SJ, Mikus CR, Laye MJ, Laughlin MH, Booth FW, Ibdah JA. (2010). Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model. J Hepatol 52:727-36.
93. Ritov VB, Menshikova EV, Azuma K, Wood R, Toledo FGS, Goodpaster BH, Ruderman NB, Kelley DE. (2010). Defciency of electron transport chain in human skeletal muscle mitochondria in type 2 diabetes mellitus and obesity. Am J Phys-Endo Metab 298:E49-58
94. Ritov VB, Menshikova EV, He J, Ferrell RE, Goodpaster BH, Kelley DE. (2005). Defciency of subsarcolemmal mitochondria in obesity and type 2 diabetes. Diabetes 54:8-14. (Pubitemid 40105089)
95. Roden M. (2005). Muscle triglycerides and mitochondrial function: possible mechanisms for the development of type 2 diabetes. Int J Obes (Lond) 29 Suppl 2:S111-15.
96. Rong JX, Qiu Y, Hansen MK, Zhu L, Zhang V, Xie M, Okamoto Y, Mattie MD, Higashiyama H, AsanoS, Strum JC, Ryan TE. (2007). Adipose mitochondrial biogenesis is suppressed in db/db and high-fat diet fed mice and improved by rosiglitazone. Diabetes 56:1751-60. (Pubitemid 47025441)
97. Samuel VT, Petersen KF, Shulman GI. (2010). Lipid-induced insulin resistance: unravelling the mechanism. Te Lancet 375:2267-77.
98. Sanyal AJ, Campbell Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, Luketi VA, Shifman ML, Clore JN. (2001). Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities. Gastroent 120:1183-92. (Pubitemid 32246672)
99. Storlien L, Oakes ND, Kelley DE. (2004). Metabolic fexibility. Proc Nutrition Soc 63:363-8.
100. Sutherland LN, Capozzi LC, Turchinsky NJ, Bell RC, Wright DC (2008). Time course of high-fat diet-induced reductions in adipose tissue mitochondrial proteins: potential mechanisms and the relationship to glucose intolerance. Am J Physiol-Endo Metab 295:E1076-83
101. Takamura T, Misu H, Matsuzawa-Nagata N, Sakurai M, Ota T, Shimizu A, Kurita S, Takeshita Y, Ando H, Honda M, Kaneko S. (2008). Obesity upregulates genes involved in oxidative phosphorylation in livers of diabetic patients. Obesity 16:2601-9.
102. Taube A, Eckardt K, Eckel J. (2009). Role of lipid-derived mediators in skeletal muscle insulin resistance. Am J Physiol Endocrinol Metab 297: E1004-E1012.
103. Toledo FG, Menshikova EV, Ritov VB, Azuma K, Radikova Z, Delany J, Kelley DE. (2007). Efects of physical activity and weight loss on skeletal muscle mitochondria and relationship with glucose control in type 2 diabetes. Diabetes 56:2142-7. (Pubitemid 47195831)
104. Toledo FG, Menshikova EV, Azuma K, Radikova Z, Kelley CA, Ritov VB, Kelley DE. (2008). Mitochondrial capacity in skeletal muscle is not stimulated by weight loss despite increases in insulin action and decreases in intramyocellular lipid content. Diabetes 57:987-94.
105. Turner N, Bruce CR, Beale SM, Hoehn KL, So T, Rolph MS, Cooney GJ. (2007). Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents. Diabetes 56:2085-92. (Pubitemid 47195821)
106. Valerio A, Cardile A, Cozzi V, Bracale R, Tedesco L, Pisconti A, Palomba L, Cantoni O, Clementi E, Moncada S, Carruba MO, Nisoli E. (2006). TNF-alpha downregulates eNOS expression and mitochondrial biogenesis in fat and muscle of obese rodents. J Clin Invest 116:2791-8. (Pubitemid 44511642)
107. van den Broek NM, Ciapaite J, de Feyter HM, Houten SM, Wanders RJ, Jeneson JA, Nicolay K, Prompers JJ. (2010). Increased mitochondrial content rescues in vivo muscle oxidative capacity in long-term high-fat-diet-fed rats. Faseb J 24:1354-64.
108. Wallace DC (2005). A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: A dawn for evolutionary medicine. Ann Rev Gen 39:359-407. (Pubitemid 43011120)
109. Wallace DC (2010). Bioenergetics, the origins of complexity, and the ascent of man. Proc Nat Acad Sci 107:8947-53.
110. Wallace DC, Fan W. (2009). Te pathophysiology of mitochondrial disease as modeled in the mouse. Genes & Devel 23:1714-36.
111. Wallace DC, Fan W. (2010). Energetics, epigenetics, mitochondrial genetics. Mitochondrion 10:12-31.
112. Wang Y, Lam KS, Lam JB, Lam MC, Leung PT, Zhou M, Xu A. (2007). Overexpression of angiopoietin-like protein 4 alters mitochondria activities and modulates methionine metabolic cycle in the liver tissues of db/db diabetic mice. Mol Endocrinol 21:972-86. (Pubitemid 46984735)
113. Weibel ER, Staubli W, Gnagi HR, Hess FA. (1969). Correlated morphometric and biochemical studies on the liver cell. J Cell Biol 42:68-91.
114. Wiesner RJ, Rüegg JC, Morano I. (1992). Counting target molecules by exponential polymerase chain reaction: Copy number of mitochondrial DNA in rat tissues. Biochem Biophys Res Comm 183:553-9.
115. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H. (2003). Chronic infammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112:1821-30. (Pubitemid 38063705)
116. Yokota T, Kinugawa S, Hirabayashi K, Matsushima S, Inoue N, Ohta Y Hamaguchi S, Sobirin MA, Ono T, Suga T, et al (2009). Oxidative stress in skeletal muscle impairs mitochondrial respiration and limits exercise capacity in type 2 diabetic mice. Am J Phys-Heart Circ Phys 297:H1069-77
117. Zimmet P, Whitehouse S, Alford F, Chisholm D. (1978). Te relationship of insulin response to a glucose stimulus over a wide range of glucose tolerance. Diabetologia 15:23-7. (Pubitemid 8363620)
118. Zorzano A, Liesa M, Palacín M. (2009a). Mitochondrial dynamics as a bridge between mitochondrial dysfunction and insulin resistance. Arch Phys Biochem 115:1-12.
119. Zorzano A, Liesa M, Palacín M. (2009b). Role of mitochondrial dynamics proteins in the pathophysiology of obesity and type 2 diabetes. Int J Biochem Cell Biol 41:1846-54.